Please upgrade your browser.
We are gravely concerned that several of the proposals offered by the President and the Congressional leadership would make matters worse, not better.
Hurdles for health care reform include the growing federal deficit, which will lead to greater scrutiny of all major initiatives. The CBO has concluded that under Obama's 2010 budget plan, government spending would continue to exceed historic levels.
The presidents opening offer of healthcare at a teaser rate fails to deliver what we actually need, value, and can afford.
Income tax changes proposed by the Obama administration could reduce charitable giving. Take this brief web poll to weigh in. So far, more than 80% say "No" to punitive changes.
"The headline ought to read, 'Smokers in America to pay for middle-class welfare.' "
A poor-prognosis form of renal cell cancer demonstrated responsiveness to chemotherapy with doxorubicin and gemcitabine (Gemzar), according to data from a small clinical study.
Socialized medicine has meant rationed care and lack of innovation. Small wonder Canadians are looking to the market.
The U.S. Food & Drug Administration has approved everolimus (brand name: Afinitor) for the treatment of advanced kidney cancer. Learn more in this audio podcast.
The U.S. Food and Drug Administration today approved Afinitor oral tablets (everolimus) for the treatment of patients with advanced kidney cancer whose disease has progressed after treatment with other cancer therapies.
MSNBC asks: If you were grading Barack Obama on his performance as president, what would he get?
|Powered by NeonCRM|